| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 583.355 | 93 |
| GSM780708 | Untreated after 4 days (C2_1) | 549.331 | 92 |
| GSM780709 | Untreated after 4 days (C3_1) | 504.331 | 92 |
| GSM780719 | Untreated after 4 days (C1_2) | 500.666 | 92 |
| GSM780720 | Untreated after 4 days (C2_2) | 640.387 | 93 |
| GSM780721 | Untreated after 4 days (C3_2) | 553.325 | 92 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 484.52 | 91 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 507.792 | 92 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 550.872 | 92 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 490.199 | 91 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 605.106 | 93 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 571.903 | 92 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 594.52 | 93 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 507.413 | 92 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 630.286 | 93 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 571.433 | 92 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 548.365 | 92 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 569.238 | 92 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 588.685 | 93 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 502.508 | 92 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 485.701 | 91 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 534.206 | 92 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 536.877 | 92 |